317 related articles for article (PubMed ID: 11527109)
1. Pharmacology of beta-blockers: classical aspects and recent developments.
Haeusler G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
[TBL] [Abstract][Full Text] [Related]
2. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
Khamssi M; Brodde OE
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
[TBL] [Abstract][Full Text] [Related]
4. Comparative properties of various beta-blockers, with an outlook to the future.
van Zwieten PA
Clin Physiol Biochem; 1990; 8 Suppl 2():18-27. PubMed ID: 1982758
[TBL] [Abstract][Full Text] [Related]
5. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
[TBL] [Abstract][Full Text] [Related]
6. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
7. Beta-receptor blockade, physical activity, and metabolism.
Lohmann FW; Loesment WA; Kaehler H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S45-52. PubMed ID: 11527136
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon--studies with cultured heart cells.
Reithmann C; Thomschke A; Werdan K
Klin Wochenschr; 1987 Apr; 65(7):308-16. PubMed ID: 2884347
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
10. Potential use of third-generation beta-blockers in heart failure.
Chatterjee K
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S22-7. PubMed ID: 2481786
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.
de Muinck ED; Lie KI
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S123-8. PubMed ID: 11527115
[TBL] [Abstract][Full Text] [Related]
12. Optimization of beta-blockers' pharmacology.
Tamargo J; Delpón E
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S10-8. PubMed ID: 11527110
[TBL] [Abstract][Full Text] [Related]
13. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
14. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
15. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
16. Evolving mechanisms of action of beta blockers: focus on nebivolol.
Mason RP; Giles TD; Sowers JR
J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G
Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
Erdmann E; Schwinger R; Böhm M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
[TBL] [Abstract][Full Text] [Related]
19. Beta blockers: the extended family.
Hager WD; Messineo FC; Katz AM
Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
[TBL] [Abstract][Full Text] [Related]
20. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
